Lucid Diagnostics (LUCD)
(Delayed Data from NSDQ)
$1.07 USD
0.00 (0.00%)
Updated Sep 18, 2025 04:00 PM ET
After-Market: $1.08 +0.01 (0.93%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/12/2025
Time: -- |
9/2025 | $-0.09 | 0.00% |
Earnings Summary
For their last quarter, Lucid Diagnostics (LUCD) reported earnings of -$0.10 per share, missing the Zacks Consensus Estimate of -$0.09 per share. This reflects a negative earnings surprise of 11.11%. Look out for LUCD's next earnings release expected on November 12, 2025. For the next earning release, we expect the company to report earnings of -$0.09 per share, reflecting a year-over-year increase of 55%.
Earnings History
Price & Consensus
Zacks News for LUCD
Rapid Micro Biosystems, Inc. (RPID) Reports Q2 Loss, Misses Revenue Estimates
LUCD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Inogen (INGN) Reports Q2 Loss, Beats Revenue Estimates
Mesa Labs (MLAB) Lags Q1 Earnings and Revenue Estimates
Hologic (HOLX) Q3 Earnings and Revenues Beat Estimates
LUCD FAQs
Based on past history, Zacks believes Lucid Diagnostics Inc. (LUCD) will report their next quarter earnings on November 12, 2025. For the next earning release, we expect the company to report earnings of -0.09 per share, reflecting a year-over-year increase of 55.00.
Based on past history, Zacks believes Lucid Diagnostics Inc. (LUCD) will report their previous quarter earnings %%TIME_OF_DAY_CODE%% on November 12, 2025.
The Zacks Consensus Estimate for Lucid Diagnostics Inc. (LUCD) for the quarter ending September 2025 is $-0.09 a share. We expect Lucid Diagnostics Inc. (LUCD) to report earnings in line with the consensus estimate of $-0.09 per share
In the earnings report for the quarter ending in June 2024, Lucid Diagnostics Inc. (LUCD) announced earnings of $-0.20 per share versus the Zacks Consensus Estimate of $ per share, representing a surprise of %.